Pfizer Inc. (PFE)
28.59
+0.63
(+2.25%)
USD |
NYSE |
Aug 31, 15:03
Pfizer Cash from Investing (Quarterly) : 2.106B for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.106B |
| March 31, 2026 | 785.00M |
| December 31, 2025 | -6.146B |
| September 30, 2025 | -2.43B |
| June 30, 2025 | 3.951B |
| March 31, 2025 | 3.274B |
| December 31, 2024 | -1.623B |
| September 30, 2024 | -2.057B |
| June 30, 2024 | 4.60B |
| March 31, 2024 | 1.732B |
| December 31, 2023 | -11.00B |
| September 30, 2023 | 888.00M |
| June 30, 2023 | -25.48B |
| March 31, 2023 | 3.315B |
| December 31, 2022 | -4.41B |
| September 30, 2022 | -4.587B |
| June 30, 2022 | -11.31B |
| March 31, 2022 | 567.00M |
| December 31, 2021 | -2.586B |
| September 30, 2021 | -10.08B |
| June 30, 2021 | -8.137B |
| March 31, 2021 | -1.747B |
| December 31, 2020 | 8.33B |
| September 30, 2020 | 481.00M |
| June 30, 2020 | -13.01B |
| Date | Value |
|---|---|
| March 31, 2020 | -71.00M |
| December 31, 2019 | -2.833B |
| September 30, 2019 | -6.76B |
| June 30, 2019 | -1.902B |
| March 31, 2019 | 7.55B |
| December 31, 2018 | -764.00M |
| September 30, 2018 | -2.904B |
| June 30, 2018 | -1.474B |
| March 31, 2018 | 9.667B |
| December 31, 2017 | -4.778B |
| September 30, 2017 | -2.992B |
| June 30, 2017 | -1.742B |
| March 31, 2017 | 4.772B |
| December 31, 2016 | -3.107B |
| September 30, 2016 | -4.381B |
| June 30, 2016 | -4.678B |
| March 31, 2016 | 4.355B |
| December 31, 2015 | -2.225B |
| September 30, 2015 | -5.243B |
| June 30, 2015 | -2.105B |
| March 31, 2015 | 6.592B |
| December 31, 2014 | -1.514B |
| September 30, 2014 | -2.535B |
| June 30, 2014 | -1.507B |
| March 31, 2014 | -98.00M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Johnson & Johnson | -1.11B |
| Eli Lilly & Co. | -15.40B |
| Merck & Co., Inc. | -5.602B |
| Bristol Myers Squibb Co. | -1.614B |
| Viatris, Inc. | -51.60M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 835.00M |
| Cash from Financing (Quarterly) | -3.663B |
| Free Cash Flow | 10.99B |
| Free Cash Flow Per Share (Quarterly) | 0.053 |
| Free Cash Flow to Equity (Quarterly) | 1.563B |
| Free Cash Flow to Firm (Quarterly) | 553.27M |
| Free Cash Flow Yield | 6.73% |